AliveGen USA, Inc., founded in 2014, is a privately held preclinical-stage biopharmaceutical company located in Thousand Oaks, California.
AREA OF FOCUS
We are focused on the discovery and development of novel biotherapeutics to combat the debilitating muscle and bone loss and the loss of functional capacity, as occurs in various neuromuscular diseases, cancer cachexia, congestive heart failure, geriatric sarcopenia and frailty, as well as in other chronic diseases, for which no approved therapies are currently available.
We aspire to improve the care and quality of life of patients by developing innovative therapies that are both highly effective and safe. To achieve this goal, we are developing a pipeline of novel next-generation clinical candidates using cutting-edge biology and protein science.